Randomized controlled trial of probiotics after colonoscopy

Area of Science:

• Gastroenterology
• Microbiology
• Clinical Medicine

Background:

• Post-colonoscopy abdominal symptoms affect up to 20% of patients.
• Symptoms may stem from gut microbiota alterations due to bowel preparation.
• Probiotics are investigated as a potential treatment to alleviate these symptoms.

Purpose of the Study:

• To evaluate the efficacy of probiotics in reducing post-colonoscopy abdominal symptoms.
• To compare probiotic intervention with placebo in symptom resolution.
• To assess the impact on pain, bloating, and bowel function.

Main Methods:

• A randomized, placebo-controlled trial was conducted.
• Participants received either a probiotic (Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07) or placebo post-colonoscopy.
• Symptom resolution (pain, bloating, bowel function) was tracked over 14 days.

Main Results:

• Probiotic use led to a significant reduction in days of abdominal pain (1.99 vs. 2.78 days, P < 0.033).
• No significant differences were observed in bloating or return to normal bowel function.
• Subgroup analysis indicated benefit for patients with pre-existing abdominal pain.

Conclusions:

• Probiotics significantly decrease the duration of abdominal pain following colonoscopy.
• Probiotic intervention did not significantly impact bloating or bowel function recovery.
• Targeted use in patients with pre-existing abdominal pain shows promise for pain management.